Click for best price
AntiCancer Drug Market Size, Share 2023
| Market size in 2022 |
US$ 86710 million
|
Forecast Market size by 2029 |
US$ 110520 million
|
| Growth Rate |
CAGR of 3.5% |
Number of Pages |
110 Pages |
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
This report aims to provide a comprehensive presentation of the global market for Anti-Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Cancer Drug. This report contains market size and forecasts of Anti-Cancer Drug in global, including the following market information:
Global Anti-Cancer Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Cancer Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Cancer Drug companies in 2022 (%)
The global Anti-Cancer Drug market was valued at US$ 86710 million in 2022 and is projected to reach US$ 110520 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
We surveyed the Anti-Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Cancer Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Cancer Drug Market Segment Percentages, by Type, 2022 (%)
Avastin
Rituxan
Herceptin
Alimta
Global Anti-Cancer Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Cancer Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Home Care
Global Anti-Cancer Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Cancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Cancer Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Cancer Drug revenues share in global market, 2022 (%)
Key companies Anti-Cancer Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Cancer Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Bristol-Myers Squibb
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche Ltd.
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Cancer Drug, market overview.
Chapter 2: Global Anti-Cancer Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Cancer Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Cancer Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-Cancer Drug Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 86710 million
|
| Forecast Market size by 2029 |
US$ 110520 million
|
| Growth Rate |
CAGR of 3.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Cancer Drug Overall Market Size
2.1 Global Anti-Cancer Drug Market Size: 2022 VS 2029
2.2 Global Anti-Cancer Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Cancer Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Cancer Drug Players in Global Market
3.2 Top Global Anti-Cancer Drug Companies Ranked by Revenue
3.3 Global Anti-Cancer Drug Revenue by Companies
3.4 Global Anti-Cancer Drug Sales by Companies
3.5 Global Anti-Cancer Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Cancer Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Cancer Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Cancer Drug Players in Global Market
3.8.1 List of Global Tier 1 Anti-Cancer Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Cancer Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Cancer Drug Market Size Markets, 2022 & 2029
4.1.2 Avastin
4.1.3 Rituxan
4.1.4 Herceptin
4.1.5 Alimta
4.2 By Type - Global Anti-Cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Anti-Cancer Drug Revenue, 2018-2023
4.2.2 By Type - Global Anti-Cancer Drug Revenue, 2024-2029
4.2.3 By Type - Global Anti-Cancer Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Cancer Drug Sales & Forecasts
4.3.1 By Type - Global Anti-Cancer Drug Sales, 2018-2023
4.3.2 By Type - Global Anti-Cancer Drug Sales, 2024-2029
4.3.3 By Type - Global Anti-Cancer Drug Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Cancer Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Cancer Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.2 By Application - Global Anti-Cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Anti-Cancer Drug Revenue, 2018-2023
5.2.2 By Application - Global Anti-Cancer Drug Revenue, 2024-2029
5.2.3 By Application - Global Anti-Cancer Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Cancer Drug Sales & Forecasts
5.3.1 By Application - Global Anti-Cancer Drug Sales, 2018-2023
5.3.2 By Application - Global Anti-Cancer Drug Sales, 2024-2029
5.3.3 By Application - Global Anti-Cancer Drug Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Cancer Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Cancer Drug Market Size, 2022 & 2029
6.2 By Region - Global Anti-Cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Anti-Cancer Drug Revenue, 2018-2023
6.2.2 By Region - Global Anti-Cancer Drug Revenue, 2024-2029
6.2.3 By Region - Global Anti-Cancer Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Cancer Drug Sales & Forecasts
6.3.1 By Region - Global Anti-Cancer Drug Sales, 2018-2023
6.3.2 By Region - Global Anti-Cancer Drug Sales, 2024-2029
6.3.3 By Region - Global Anti-Cancer Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Cancer Drug Revenue, 2018-2029
6.4.2 By Country - North America Anti-Cancer Drug Sales, 2018-2029
6.4.3 US Anti-Cancer Drug Market Size, 2018-2029
6.4.4 Canada Anti-Cancer Drug Market Size, 2018-2029
6.4.5 Mexico Anti-Cancer Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Cancer Drug Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Cancer Drug Sales, 2018-2029
6.5.3 Germany Anti-Cancer Drug Market Size, 2018-2029
6.5.4 France Anti-Cancer Drug Market Size, 2018-2029
6.5.5 U.K. Anti-Cancer Drug Market Size, 2018-2029
6.5.6 Italy Anti-Cancer Drug Market Size, 2018-2029
6.5.7 Russia Anti-Cancer Drug Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Cancer Drug Market Size, 2018-2029
6.5.9 Benelux Anti-Cancer Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Cancer Drug Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Cancer Drug Sales, 2018-2029
6.6.3 China Anti-Cancer Drug Market Size, 2018-2029
6.6.4 Japan Anti-Cancer Drug Market Size, 2018-2029
6.6.5 South Korea Anti-Cancer Drug Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Cancer Drug Market Size, 2018-2029
6.6.7 India Anti-Cancer Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Cancer Drug Revenue, 2018-2029
6.7.2 By Country - South America Anti-Cancer Drug Sales, 2018-2029
6.7.3 Brazil Anti-Cancer Drug Market Size, 2018-2029
6.7.4 Argentina Anti-Cancer Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Cancer Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Cancer Drug Sales, 2018-2029
6.8.3 Turkey Anti-Cancer Drug Market Size, 2018-2029
6.8.4 Israel Anti-Cancer Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Cancer Drug Market Size, 2018-2029
6.8.6 UAE Anti-Cancer Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Anti-Cancer Drug Major Product Offerings
7.1.4 Merck Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Anti-Cancer Drug Major Product Offerings
7.2.4 Bristol-Myers Squibb Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anti-Cancer Drug Major Product Offerings
7.3.4 Bayer Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Anti-Cancer Drug Major Product Offerings
7.4.4 GlaxoSmithKline Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anti-Cancer Drug Major Product Offerings
7.5.4 Novartis Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Anti-Cancer Drug Major Product Offerings
7.6.4 Sanofi Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Anti-Cancer Drug Major Product Offerings
7.7.4 Pfizer Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Anti-Cancer Drug Major Product Offerings
7.8.4 Amgen Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 Celgene Corporation
7.9.1 Celgene Corporation Company Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Anti-Cancer Drug Major Product Offerings
7.9.4 Celgene Corporation Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.9.5 Celgene Corporation Key News & Latest Developments
7.10 Ariad Pharmaceuticals
7.10.1 Ariad Pharmaceuticals Company Summary
7.10.2 Ariad Pharmaceuticals Business Overview
7.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Major Product Offerings
7.10.4 Ariad Pharmaceuticals Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.10.5 Ariad Pharmaceuticals Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Anti-Cancer Drug Business Overview
7.11.3 Eli Lilly Anti-Cancer Drug Major Product Offerings
7.11.4 Eli Lilly Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 Hoffmann-La Roche Ltd.
7.12.1 Hoffmann-La Roche Ltd. Company Summary
7.12.2 Hoffmann-La Roche Ltd. Anti-Cancer Drug Business Overview
7.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Major Product Offerings
7.12.4 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.12.5 Hoffmann-La Roche Ltd. Key News & Latest Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Company Summary
7.13.2 AstraZeneca Anti-Cancer Drug Business Overview
7.13.3 AstraZeneca Anti-Cancer Drug Major Product Offerings
7.13.4 AstraZeneca Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.13.5 AstraZeneca Key News & Latest Developments
7.14 Boehringer Ingelheim GmbH
7.14.1 Boehringer Ingelheim GmbH Company Summary
7.14.2 Boehringer Ingelheim GmbH Business Overview
7.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Major Product Offerings
7.14.4 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.14.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.15 Teva Pharmaceuticals
7.15.1 Teva Pharmaceuticals Company Summary
7.15.2 Teva Pharmaceuticals Business Overview
7.15.3 Teva Pharmaceuticals Anti-Cancer Drug Major Product Offerings
7.15.4 Teva Pharmaceuticals Anti-Cancer Drug Sales and Revenue in Global (2018-2023)
7.15.5 Teva Pharmaceuticals Key News & Latest Developments
8 Global Anti-Cancer Drug Production Capacity, Analysis
8.1 Global Anti-Cancer Drug Production Capacity, 2018-2029
8.2 Anti-Cancer Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Cancer Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Cancer Drug Supply Chain Analysis
10.1 Anti-Cancer Drug Industry Value Chain
10.2 Anti-Cancer Drug Upstream Market
10.3 Anti-Cancer Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Cancer Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Cancer Drug in Global Market
Table 2. Top Anti-Cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Cancer Drug Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Cancer Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Cancer Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Cancer Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Cancer Drug Product Type
Table 9. List of Global Tier 1 Anti-Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Cancer Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Cancer Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Cancer Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Cancer Drug Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Cancer Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Cancer Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Cancer Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Cancer Drug Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Cancer Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Cancer Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Cancer Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Cancer Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Cancer Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Cancer Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Cancer Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Cancer Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Cancer Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Cancer Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Cancer Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Cancer Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Cancer Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Cancer Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Cancer Drug Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Anti-Cancer Drug Product Offerings
Table 48. Merck Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Anti-Cancer Drug Product Offerings
Table 52. Bristol-Myers Squibb Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Anti-Cancer Drug Product Offerings
Table 56. Bayer Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Anti-Cancer Drug Product Offerings
Table 60. GlaxoSmithKline Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Anti-Cancer Drug Product Offerings
Table 64. Novartis Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Anti-Cancer Drug Product Offerings
Table 68. Sanofi Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Anti-Cancer Drug Product Offerings
Table 72. Pfizer Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Amgen Company Summary
Table 75. Amgen Anti-Cancer Drug Product Offerings
Table 76. Amgen Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Amgen Key News & Latest Developments
Table 78. Celgene Corporation Company Summary
Table 79. Celgene Corporation Anti-Cancer Drug Product Offerings
Table 80. Celgene Corporation Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Celgene Corporation Key News & Latest Developments
Table 82. Ariad Pharmaceuticals Company Summary
Table 83. Ariad Pharmaceuticals Anti-Cancer Drug Product Offerings
Table 84. Ariad Pharmaceuticals Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Ariad Pharmaceuticals Key News & Latest Developments
Table 86. Eli Lilly Company Summary
Table 87. Eli Lilly Anti-Cancer Drug Product Offerings
Table 88. Eli Lilly Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Eli Lilly Key News & Latest Developments
Table 90. Hoffmann-La Roche Ltd. Company Summary
Table 91. Hoffmann-La Roche Ltd. Anti-Cancer Drug Product Offerings
Table 92. Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 94. AstraZeneca Company Summary
Table 95. AstraZeneca Anti-Cancer Drug Product Offerings
Table 96. AstraZeneca Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. AstraZeneca Key News & Latest Developments
Table 98. Boehringer Ingelheim GmbH Company Summary
Table 99. Boehringer Ingelheim GmbH Anti-Cancer Drug Product Offerings
Table 100. Boehringer Ingelheim GmbH Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 102. Teva Pharmaceuticals Company Summary
Table 103. Teva Pharmaceuticals Anti-Cancer Drug Product Offerings
Table 104. Teva Pharmaceuticals Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Teva Pharmaceuticals Key News & Latest Developments
Table 106. Anti-Cancer Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Anti-Cancer Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Anti-Cancer Drug Production by Region, 2018-2023 (K Units)
Table 109. Global Anti-Cancer Drug Production by Region, 2024-2029 (K Units)
Table 110. Anti-Cancer Drug Market Opportunities & Trends in Global Market
Table 111. Anti-Cancer Drug Market Drivers in Global Market
Table 112. Anti-Cancer Drug Market Restraints in Global Market
Table 113. Anti-Cancer Drug Raw Materials
Table 114. Anti-Cancer Drug Raw Materials Suppliers in Global Market
Table 115. Typical Anti-Cancer Drug Downstream
Table 116. Anti-Cancer Drug Downstream Clients in Global Market
Table 117. Anti-Cancer Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Cancer Drug Segment by Type in 2022
Figure 2. Anti-Cancer Drug Segment by Application in 2022
Figure 3. Global Anti-Cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Cancer Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Cancer Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Cancer Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Cancer Drug Revenue in 2022
Figure 9. By Type - Global Anti-Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Cancer Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Cancer Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Cancer Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 23. US Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 28. Germany Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 37. China Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Cancer Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Cancer Drug Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Cancer Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Cancer Drug by Region, 2022 VS 2029
Figure 54. Anti-Cancer Drug Industry Value Chain
Figure 55. Marketing Channels
